Causes of breathlessness
Lungs - cardiovascular issues Anxiety e.g hyperventilation poisoning - CO poisoning , cyanide Endocrine - Hyperthyroidism musculoskeletal - myasthenia gravis, Guillain barre syndrome (if you have respiratory breathing difficulties Hematology - anaemia
1;2 ration of inspiration to expiration.
what you may see in a respiratory exam
in obstruction condition - body breathes in fast to give body longer to breathe out to get rid of built up air in the lungs.
pursed lips breathing - tell you someone has got airway obstruction.
accesory muscle - if using other muscle e.g holding on to something - using more effort to breathe - abnormal .
Stridor - (outside chest - inspiration
wheeze - inside chest - expiration)
(but you may hear each of them in either inspiration or expiration)
(all caused by airway narrowing)
cor pulmonale
if they yawn & sigh a lot - if you have strong drive to breathe - feeling like they are not getting enough air in.
if you feel breathless - ASK patient when they get breathless.
onbstructive sleep apnoea
during slee- - gravity is waying on our airways & if the is a weight then the airways narrow.
as they stop ventilation - oxygen sat drops, when ventilation starts again - oxygen sats pick up.
peak flow - reduction with reduction in airway diameter
asthma etc - cause airway narrowing
spirometry - how much you have breathed out related to time ( 70 % in the 1 sec - normal )
on the spirometry page - if there is a restrictive picture - the graph will have the same shape , only the litres of air involved will be less.
(fev1/FVC - small
gas transfer measurement - residual volume. ## ventilation /perfusion ratio - dye defects back were blood is . if area of black is less - lack of perfusion (PE)
pulse oximerty around the block -
What is COPD ?
Chronic Obstructive pulmonary disease.
Group of lung conditions tat cause breathing difficulties including :
0 emphysema (damage to air sacs —–> loss of elasticity —–> means unable to maintain shape & become larger (unable to rebound) , smaller SA : V ratio (less efficient gas exchange)
0 Chronic bronchitis long term inflammation of bronchi ——> causes mucus build up——–> swelling + mucus make it hard for CO2 to get out (C02 retention)
(These are types of COPD)
CAUSES :
Exposure to irritants e.g. smoking
SIGNS/ SYMPTOMS - * (means most important )
*WHEEZE - common in excaerbations
- expiratory wheeze
or
polyphonic wheeze (multiple pitches / notes starting & ending at the same time.
(sign of inflammation & resistance
COARSE CRACKLES - indicates airway inflammation & muscus over -secretion.
RISK FACTORS
WEAKER
COMPLICATIONS OF CO2
(breathing difficulties ———————> drop in serum 02 levels ————-> body increase BP ———————————-> pulmonary hypertension ——————————> Right sided heart failure ————————————–> Cor pulmonale ( impairment of right side of heart bcc of respiratory disease)
SIGNS
0 Distended neck veins 0 cyanosis 0 Loud P2 0 hepatosplenomegaly 0 hepatojugular reflux ( manual pressure applied to liver - if neck veins , distend - positive) - ankle swelling (peripheral oedema) - systolic parasternal heave. -
DIagnosis of COPD ?
Spirometry - needed for confirmation of diagnosis
(FEV1/FVC ration below 0.7 )
COPD can exist with other conditions.
0 FBC
0 CXR
CONSIDER
0 ECG & serum natriuretic peptides - if cardiac disease r pulmonary hypertension suspected.
0 echocardiogarm - if pulomary hypertension suspected .
0 CT thorax - if sysmptoms seem disproportionate to spirometry results - may indicate another condition e.g fibrosis , bronchiectasis.
0 Serum alpha - 1 - antitryspin.
if acute presentation & breathing difficulties :
0 SERIAL PEAK FLOW MEASUREMENT - to exclude asthma if in doubt.
0 Sputum culture -if frequent excaberations , sever airflow limitation , exacberations requirng mechanical ventilation (SPUTUM SHOULD BE SENT FOR CULTURE - IN THESE CASES. )
What are the criteria for stages of COPD ?
4 stages (GOLD - Global initiative for Chronic Obstructive Lung disease)
0 Gold 1- mild (FEV1 > 80 % )
0 Gold 2 - moderate - 50 % - 80 %
0 Gold 3 - Severe - below 50 %
0 Gold 4 - Very severe - below 30 % FEV1
FEV1 - forced expiratory volume (the amount of air you can force out in one second - COPD prevents breathing out (causing co2 uild up)
What is mMRC dyspnoea scale ?
Modified medical research council dyspnea scale
Determines the severity of dyspnoea in respiratory disease i.e. COPD.
0 - 4 Points
0 - dyspnoea on excretion
1- Dyspnoea when hurrying or walking up slight hill
2- walks slower than pl of same age bcc of dyspnoea or has to stop for breath when walking at own pace
3- Stop for breath after walking 91 m (100 YARDS ) or after a few mins.
4 - Too dyspneic to leave house or breathless when dressing.
This can be incorpated into the GOLD critera for COPD when trying to assess more breathless patients .
0 Group A: low risk (0-1 exacerbation per year, not requiring hospitalisation) and fewer symptoms (mMRC 0-1 or CAT <10)
0 Group B: low risk (0-1 exacerbation per year, not requiring hospitalisation) and more symptoms (mMRC≥ 2 or CAT≥ 10)
0 Group C: high risk (≥2 exacerbations per year, or one or more requiring hospitalisation) and fewer symptoms (mMRC 0-1 or CAT <10)
0 Group D: high risk (≥2 exacerbations per year, or one or more requiring hospitalisation) and more symptoms (mMRC≥ 2 or CAT≥ 10).
Treatment of COPD ?
(if patient is breathless and has exercise limitation)
1ST LINE - short acting or long acting bronchodilator (short acting BETA -2 - AGONIST (SABA) , short acting muscarinic antagonist (SAMA)
0 short acting Beta - 2 - agonist (salbutamol )
or
0 short acting muscarinic antagonist (SAMA) - ipratropium
( these used to reduce breathlessness & increase excercise tolerance.
if not working & supportice care (non -pharmological ) is optimal use & NO ASTHMATIC FEATURES use:
2ND LINE
LABA + LAMA
( long acting beta -2 agonist ( salmeterol , formoterol , vilanterol ) + long acting muscarinic anatgonist - aclidinium , glycopyrronium , umeclidium )
3RD LINE
(trail of LABA + LAMA + inhaled cortiocosteriod (ICS ) - for 3 months
(if improved keep combination - review anually )
4TH LINE - if no improvement - go back to LABA + LAMA
add on treatments
- Oral mucolytic therapy ( if person with stable COPD develops chronic productive cough)
(erdosteine , acetylcysteine , carbocisteine
(mucolytics - dissolve thick mucus)
(STEINES)
Mechanism of action of different types of bronchiodilators ?
examples of bronchiodilators
0 Beta - 2 - agonist
( B2 receptors when activated cause smooth muscle dilation of airways )
( (salbutamol , Terbutaine-SABA - short acting ) , salmeterol , formoterol , vilanterol - LABA (rest of these are Long acting - TEROLS)
0 Anticholinergics / muscarinic anatgonists
(block actelycholine which is responsible for involuntary muscle movements )
(ipratropium - SABA, tiotropium , aclidinium , glycopyrronium, umeclidium - LABA - PIUM)
0 ADD ON TREATMENT Theophylline (Xanthines - relax muscles around airways so they open up more easily , also decrease lungs response to irritants
(
Oral theophylline - should only be considered after trail of short & long bronchiodilators have beem used & inhaled corticosteriods cannot be used) - hIGH RISK , NARROW THERAPEUTIC RATIO , FREQUENT DRUG-DRUG INTERACTIONS
Which groups should use Beta - 2 agonists with caution ?
Effects Potassium levels (so will affect cardiac system - be careful in cardiovascular disease)
Hyperthyroidism — beta-2 agonists may stimulate thyroid activity.
0 Diabetes mellitus — there is a rare risk of ketoacidosis (especially after intravenous beta-2 agonist administration). Additional blood glucose measurements are recommended when treatment with a beta-2 agonist is commenced.
0 Cardiovascular disease (including hypertension) — beta-2 agonists may cause an increased risk of arrhythmias and significant changes to blood pressure and heart rate.
Susceptibility to QT-interval prolongation.
0 Hypokalaemia — plasma potassium concentration may be reduced by beta-2 agonists (particularly high doses).
0 Convulsive disorders.
Side effects - heart - QT prolongatiion - palapitations - cardiac arrythmias - rare
(Neurological) Seizures Fine tremour headache anxiety
(Lungs )
- bronchospasm - rare
Differenitals of COPD ?
Asthma - usually happens early in life , - personal history of allergic rhinitis : 0 eczema 0 allergic rhinitis (atopy triad - together with asthma)
Investiagtions - Spirometry & PFTs show reversibility with bronchiodilators.
* if sputum or blood shows eosinophillia (high levels of eosinphils )- sign of type of severe asthma - marked by high WBC - high levels of eosinophils cause swelling & inflammation of airway - rare)
0 Bronchiectasis ( long term condition where airways become widened & mucus builds up)
* some patients can develop bronchiectasis as a result of COPD)
(Bronchiectasis - is caused by lung infection , immunodieficency, aspiration (airway is senstive to gastric contents so can trigger inflammation, Cystic fibrosis - complication - as mucus is a good evironment for infection) , cillia abnormalities , connective tissue disorders (RA , Sjogren’s syndrome , crohn’s disease , UC)
* 1 IN 3 CASES ARE ASSOCIATED WITH SEVERE LUNG INFECTION IN CHILDHOOD ( TB , whooping cough , measles , severe pneumonia)
- history of recurrent lung infection in childhood (especially Hx of TB or whooping cough (pertussis)
- Large volume of prulent content present.
0 CHF -
usually :
history of Cardiovascular disease present , othropnoea & inspiratory crackles
(raised B -nauiretic protein X ray shows pulmonary vascular congestion & echo confirms this)
0 TB -
signs - Hx of fever , night sweats , weight loss , chronic productive cough
microbiological confirmation
- granuloma , fibrosis , inflitates seen on X RAY
- positive skin test for TB
0 ACE inhibitor induced cough - ACE inhibitors cause chronic cough - NOT USUALLY PRODUCTIVE. (cough improves when ACE stopped )
0 Chronic sinusitis / rhinitis - common cause of chronic cough
(Hx of sinus pressure , runny nose (rhinorrhoea , non -productive cough , headache)
rrhoea - flow / discharge
0 GORD - chronic cough can occur especially when supine - worsens at night
(accompained with GORD symptoms (dyspepsia , frequent bletching )
0 LUNG CANCER - COPD INCREASED RISK OF LUNG CANCER
(weight loss , neight sewats , haempytsis , chest , back pain.
0 Upper airway dysfunction
0 Bronchiolitis - inflammation of the bronchioles (post infectious , Hx of connective tissue disorders , fume exposure)
CXR - hyperinflation
What is a COPD excaebation ?
exacerbation of COPD - acute worsening of respiratory symptoms that results in additional therapy .
SIGNS /SYMPTOMS
0 Wheeze
(beware of decreased breath sound - indicates impending respiratory failure.)
0 tachypnoea - could be respiratory failure
0 Cor pulmonale (could occur due to exacerbation - induced hypoxaemia ) - peripheral oedema elevated JVP - hepatojugular reflux systoluc parasternal heave - relative hypotension - loud pulmonary second heart sounds
Just for knowledge - practical tip to differentiate upper airway sound from wheeze?
Transmitted upper airway noise ‘wheeze’ is common both as a symptom and as a sign. Be aware that patients or relatives may describe ‘wheeze’, especially on exertion, that is actually upper airway transmitted noise and not wheeze. Consider this on auscultation. Likewise wheeze heard at the end of the bed is often from the upper airway rather than small airways and may not improve with usual COPD treatment.
INVESTIGATIONS
0 Pulse oximetry (community & hoospital )
0 ECG, Vitamin D ( can be done commmunity if possible & hospital )
REST CAN ONLY BE DONE IN HOSPITAL - FOR MODERATE TO SEVERE EXACERBATIONS) do :
Signs of respiratory failure ?
0 Change in mental status
0 Morning headaches
(sign of worsening hypercapnic ventilatory failure. )
0 accessory muscle use
& pursed lips breathing.
0 Paradoxial movement of the abdomen ( SEE SAW BREATHING)
Respiratory failure ( Pa02 below 8.0 KPA)
Types of breathing support / assistance ? - oxygen delivery devices ?
NIV - NON - INVASIVE VENTILATORY SUPPORT - delivery of O2 via a face mask - no need for endotracheal airway.
Treatment of excaberbation of COPD ?
1ST LINE
Oral corticosteriods - Prednisolone 5 days 30mg- FOR ALL THOSE ADMITTED TO HOSPITAL OR SIGNIFICANT INCREASE IN BREATHLESSNESS.
IF BACTERIAL INFECTION PRESENT
ORAL ANTIBIOTICS
- (amoxicillin, doxycycline , clathromyocin )
2ND LINE - if this does not work (pick another of those 3 )
if higher risk of treatment failure
(Co - amoxiclav , , Co - trimoxazole , IF THESE NOT POSSIBLE / WORKING levofloxacin)
3RD LINE
IV ANTIBIOTICS
What is asthma ?
same guy that did tonsilitis .
Chronic respiratory condition associated with airway inflammation & hyper-responsiveness
(airway hyperresponsiveness - pre - disposition of airways to narrow excessively in response to stimuli) that would not really affect heathy pl. ————————-> leads to recurrent wheezing , breathlessness , chest tightness , coughing - resulting in variable airway obstruction that is reversible either spontaneously or with treatment.
SIGNS & SYMPTOMS
(MAINLY LOOK FOR
0 Cough , breathlessness , expiratory wheeze & daily or seasonal changes in symptoms
0 FHx or Hx of atopic disorders
0 Any triggers that make it worse. )
RISK FACTORS
Investigations / Diagnosis of asthma ? - 17 & above (note children aged 5 - 16 are similar but slight differences )
Diagnose asthma :
or
or Postive BDR + Positive peak flow varibility
Suspect asthma with :
- Negative BDR , FeN0 > 40 ppm or btw 25 & 39 with peak flow varibility
or
Positive BDR + FeN0 level btw 25 - 29 ppb with negative peak flow varibility .
(review diagnoses 6 -10 weeks after)
Order of diagnosis
HIstory ————> Exam (respiratory - may be normal in people with asthma )———————> Objective testing - offer all 3 - (Spirometry , feNO , peak flow) ———————-> Bronchodilator reversibility test (BDR)( for aged over 17 with obstructive spirometry (FEV1 /FVC < 70 %) ——————–> Diagnostic uncertainity do : monitoring of peak flow variability for 2 to 4 weeks - 20 % variability - POSITIVE / ——> Bronchial challenge test (see requirements below) —————————->
Explanation of test
spirometry - aged over 5
FeNO - aged over 17
0 Spiromtery (FEV1/FVC 40 ppm + no variability in peak flow
or
0 FeN0 < 40 ppm + variability in peak flow)
(may be used if spirometry has been done but doctors not sure if you still have asthma.
(other names - airway provocation test - look to see if patient has sensitive airways - increasing doses of medicine that constrict / irritate the airways (e.g histamine , methacholine ) are breathed in. Pl with sensitive airways / asthma are affected by much lower doses. )
0 FeNO - fractional exhaled nitric oxide test ( test how much NO is in you breath - higher levels indicate asthma - MORE THAN 40 PPB (parts per billion)
* beware that smoking can lower levels.
0 Bronchodilator reversibility test (IMPROVEMENT OF FEV1 OF MORE THAN 12 % + increase in volume of 200 or more - POSITIVE )
OTHER TEST - NOT DIAGNOSTIC
FOLLOWING TEST ARE NOT DIAGNOSTIC - USED TO IDENTIFY ALLERGEN AFTER FORMAL DIAGNOSIS MADE (on if allergy is present ) :
Treatment of asthma for ages 17 & over ?
Infrequent asmtha symptoms , short lived wheeze + normal function
1 ST LINE
reliever therapy
SABA - e.g salbutamol
2ND LINE
Low dose ICS
If maintence therapy needed e.g frequent asthma symptoms (3 or more times a weeks ) or waking at night.
1ST LINE
low dose ICS
2ND LINE
Lose dose ICS + LTRA (leukotriene receptor antagonist e.g . Montelukast , zafirlukast)
3RD LINE
Low dose ICS + LABA +/- LTRA
( discuss whether to continue LTRA)
4TH LINE
MART - maintence and reliever therapy combines ICS with LABA in single inhaler) - low dose ICS used +/= LTRA
5TH LINE
MART - medium dose of ICS
or fixed dose of ICS , LABA with a SABA
( + /- LTRA)
6TH LINE
or trail of addition drug e.g. LMRA (muscarinic antagonist) or theophylline.
SELF MANAGEMENT - ADVICE ON AVOIDANCE OF EXPOSURE TO POLLUTANTS , ALLERGENS
- they have self management plan on how to deal with asthma if deteroriates e.g . Doctor prescribes a specific increased dose to take for 7 days etc.
CONSIDER REDUCING MAINTENCE THERAPY IF SYSMPTOMS CONTROLLED FOR 3 MONTHS .
(only consider stopping low ICS treatment if symptoms free)
Treatment of asthma aged below 5 ?
1ST LINE
SABA - reliever therapy
IF maintence therapy needed bcc frequent asthma symptoms or SABA not enough
1ST LINE - use SABA alongside as reliever therapy
8 week trial of moderate of ICS
(stop after 8 weeks to monitor child symptoms)
2ND LINE - if uncontrolled on low dose ICS ADD LTRA (Montelukast etc)
3RD LINE - stop LTRA - refer to specialist
Treatment of asthma of those aged 5 -16 ?
Infrequent asmtha symptoms , short lived wheeze + normal function
1 ST LINE
reliever therapy
SABA - e.g salbutamol
f maintence therapy needed e.g frequent asthma symptoms (3 or more times a weeks ) or waking at night.
1ST LINE
pediatric low dose ICS
2ND LINE
Lose dose ICS + LTRA (leukotriene receptor antagonist e.g . Montelukast , zafirlukast) ( review treatment response in 4 tp 8 weeks .
3RD LINE
consider Lose dose ICS + LABA (stop LTRA)
4TH LINE
consider MART ( containing pedriatric low dose ICS & A LABA)
5TH LINE
consider seeking opinion of specialist
and consider :
SELF MANAGEMENT - ADVICE ON AVOIDANCE OF EXPOSURE TO POLLUTANTS , ALLERGENS
- they have self management plan on how to deal with asthma if deteroriates e.g . Doctor prescribes a specific increased dose to take for 7 days etc.
-
How to treat severe asthma ?
Not controlled by standard therapy
Omalizumab (AGED OVER 6)- if severe persistent confirmed allergic IgE mediated asthma.
for severe eosphillic asthma
Mepolizumab
Benralizumab
reslizumab
(there are some conditions for their usage but could not be bothered to write )
Diagnostic criteria for asthma (5 - 16 years )
0 FeN0 >/= 35ppm + peak flow varibility
0 or obstructive spirometry and positive BDR.
Under 5s dont do objective test , clinical jugdement is used + symptoms.
What is acute exacerbation of asthma ?
Subacute worsening of symptoms of asthma including :
( will reduction in baseline levels on objective tests e.g peak flow , spirometry , FeNO etc.)
may also be :
life threatening
OE :
RISK FACTORS
Diagnosis of asthma excaerbation ?
non verbal behaviour e.g agigitation (especially children), altered conciousness —————–> appearence (is there signs of hpoxia - cyanosis , use of accessory muscles ) ——————-> examine - RR , BP , pulse —————————–> record Peak flow expiratory rate———————-> measure oxygen sat .
0 arterial blood gas
0 peak flow
0 pulse oximetry
0 CXR
consider : 0 FBC - eosinophilla (eosinophil asthma ) 0 U & E 0 CRP 0 Theophylline (if on this ) 0 ECG
Grading of severity of acute exacerbation?
Adults
Children
0 MODERATE -
+ normal speech with no features of acute severe or threatening asthma.
ACUTE SEVERE - PEFR 33 - 50 % - PEFR (less than 50 % children ) or RR - 25 or more / Pulse rate of 110 or above ( above 12 yrs)
RR- 30 or more (5 -12 yrs )
PR - 125 or more
RR - above 40
PR - above 140 (below 2- 5 )
OR either one of these; inability to complete sentences in one breath - acessory muscle use - inability ro feed (infants ) WITH OXYGEN SAT OF 92 % or above
LIFE- THREATENING
- PEFR 33 % below
or
- oxygen sat - below 92 %
either of these :